Assessment of the Relationship Between ABO Blood Group and Familial Cancer Occurrence in Kirkuk City
Relationship Between ABO Blood Group and Familial Cancer Occurrence in Kirkuk City
DOI:
https://doi.org/10.31661/gmj.v14i.3813Keywords:
ABO Blood Groups; Cancer; Iraq; Familial CancerAbstract
Background: The potential connection between blood types and cancer risk has become a puzzling yet intriguing area of research in recent years; while its association is widely assessed with cancer occurrence, it is not well assessed in case of hereditary cancers. This study aimed to assess the relation between ABO blood groups and the occurrence of familial cancers. Materials and Methods: This cross-sectional study was carried out in Kirkuk city from the period 15th October 2023 to 15th April 2024 on 398 patients diagnosed with cancer. The study included three groups: patients with a family history of cancer in first-degree relatives (n=90), no family history (n=288), and second-degree relatives (n=20). Data was collected from both medical records and patient interviews, focusing on demographic details, lifestyle habits, medical history. In-depth interviews provided further details on lifestyle patterns, including smoking habits, alcohol use, eating habits, medical conditions, medication use, viral infections, and exposure to chemicals or radiation. Results: Significant differences were noted in age distribution, with the 38-47 and 48-57 age groups being more common in the first-degree and no family history groups, respectively. Sex distribution showed a higher proportion of females in the first-degree and second-degree groups (P=0.017). There were higher proportions of high socioeconomic status in the second-degree group and married individuals in the first-degree and second-degree groups compared to non-familial cancers. Breast cancer was more prevalent in the first-degree and second-degree groups. Adjusting for demographic, socioeconomic, Body-Mass-Index, cancer type, and health related habits, O- blood group was significantly associated with a higher likelihood of familial cancer history in first-degree relatives (OR: 14.083, P=0.024) compared to non-familial ones. Other blood groups did not show significant associations. Conclusion: There might be an association between familial cancer O- blood group that needs to be re-evaluated in further studies.
References
Abegaz SB. Human ABO blood groups and their associations with different diseases. BioMed research international. 2021 Jan 23;2021:1-9.
https://doi.org/10.1155/2021/6629060
PMid:33564677 PMCid:PMC7850852
Annual Statistical Report 2019. Planning Directorate, Ministry of Health/Environment, Republic of Iraq, 2019. https://moh.gov.iq/upload/upfile/ar/1070.pdf. Accessed 25 Oct 2020.
Dotz V, Wuhrer M. Histo-blood group glycans in the context of personalized medicine. Biochimica et Biophysica Acta (BBA)-General Subjects. 2016 Aug 1;1860(8):1596-607.
https://doi.org/10.1016/j.bbagen.2015.12.026
PMid:26748235 PMCid:PMC7117023
Franchini M, Bonfanti C. Evolutionary aspects of ABO blood group in humans. Clinica chimica acta. 2015 Apr 15;444:66-71.
https://doi.org/10.1016/j.cca.2015.02.016
PMid:25689219
Huang JY, Wang R, Gao YT, Yuan JM. ABO blood type and the risk of cancer-Findings from the Shanghai Cohort Study. PloS one. 2017 Sep 7;12(9): e0184295.
https://doi.org/10.1371/journal.pone.0184295
PMid:28880901 PMCid:PMC5589178
Lukong KE. Understanding breast cancer-The long and winding road. BBA clinical. 2017 Jun 1;7:64-77.
https://doi.org/10.1016/j.bbacli.2017.01.001
PMid:28194329 PMCid:PMC5300293
Miranda JJ, Kinra S, Casas JP, Davey Smith G, Ebrahim S. Non‐communicable diseases in low‐and middle‐income countries: context, determinants and health policy. Tropical Medicine & International Health. 2008 Oct;13(10):1225-34.
https://doi.org/10.1111/j.1365-3156.2008.02116.x
PMid:18937743 PMCid:PMC2687091
Hussein ZS. Relationship between the ABO blood group and lung cancer susceptibility. Medical Journal of Babylon. 2021 Apr 1;18(2):80-2.
https://doi.org/10.4103/MJBL.MJBL_91_20
Tavares V, Pinto R, Assis J, Pereira D, Medeiros R. Venous thromboembolism GWAS reported genetic makeup and the hallmarks of cancer: Linkage to ovarian tumour behaviour. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 2020 Jan 1;1873(1):188331.
https://doi.org/10.1016/j.bbcan.2019.188331
PMid:31689458
Zaki SM, Hasan FF, Saydoka KM, Amin NA. The association and relation of ABO blood group with the breast cancer in Kirkuk governorate. Diyala Journal of Medicine. 2013;5(1):108-13.
Cui H, Qu Y, Zhang L, Zhang W, Yan P, Yang C, Zhang M, Bai Y, Tang M, Wang Y, Chen L. Epidemiological and genetic evidence for the relationship between ABO blood group and human cancer. International Journal of Cancer. 2023 Jul 15;153(2):320-30.
https://doi.org/10.1002/ijc.34533
PMid:37074298
Zhang BL, He N, Huang YB, Song FJ, Chen KX. ABO blood groups and risk of cancer: a systematic review and meta-analysis. Asian Pacific Journal of Cancer Prevention. 2014;15(11):4643-50.
https://doi.org/10.7314/APJCP.2014.15.11.4643
PMid:24969898
Gates MA, Xu M, Chen WY, Kraft P, Hankinson SE, Wolpin BM. ABO blood group and breast cancer incidence and survival. International journal of cancer. 2012 May 1;130(9):2129-37.
https://doi.org/10.1002/ijc.26220
PMid:21633955 PMCid:PMC3655700
Joudaki N, Khodadadi A, Talaiezadeh A, Jodat H, Jodat J, Asadirad A. Study of the Relationship between ABO Blood Group Types and Breast Cancer and Cervix Cancer in Khuzestan Province, Iran. International Journal of Hematology-Oncology and Stem Cell Research. 2023 Apr 4;17(2):65.
https://doi.org/10.18502/ijhoscr.v17i2.12642
Wojdacz TK, Harari F, Vahter M, Broberg K. Discordant pattern of BRCA1 gene epimutation in blood between mothers and daughters. Journal of Clinical Pathology. 2015 Jul 1;68(7):575-7.
https://doi.org/10.1136/jclinpath-2015-202982
PMid:25878326
Antwi SO, Rabe KG, Bamlet WR, Meyer M, Chandra S, Fagan SE, Hu C, Couch FJ, McWilliams RR, Oberg AL, Petersen GM. Influence of cancer susceptibility gene mutations and ABO blood group of pancreatic cancer probands on concomitant risk to first-degree relatives. Cancer Epidemiology, Biomarkers & Prevention. 2022 Feb 1;31(2):372-81.
https://doi.org/10.1158/1055-9965.EPI-21-0745
PMid:34782396 PMCid:PMC8825751
Urun Y, Ozdemir NY, Utkan G, Akbulut H, Savas B, Oksuzoglu B, et al. ABO and Rh blood groups and risk of colorectal adenocarcinoma. Asian Pacific Journal of Cancer Prevention. 2012;13(12):6097-100.
https://doi.org/10.7314/APJCP.2012.13.12.6097
PMid:23464411
Kim J, Yuan C, Amundadottir LT, Wolpin BM, Pancreatic Cancer Cohort Consortium (PanScan), Klein AP, Pancreatic Cancer Case-Control Consortium (PanC4), Risch HA, Kraft P. Relationship between ABO blood group alleles and pancreatic cancer is modulated by secretor (FUT2) genotype, but not Lewis antigen (FUT3) genotype. Cancer Epidemiology, Biomarkers & Prevention. 2023 Sep 1;32(9):1242-8.
https://doi.org/10.1158/1055-9965.EPI-23-0009
PMid:37342060 PMCid:PMC10527950
Hakomori SI. Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochimica et Biophysica Acta (BBA)-General Subjects. 1999 Dec 17;1473(1):247-66.

Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Galen Medical Journal

This work is licensed under a Creative Commons Attribution 4.0 International License.